PAPER Osera C, Fassina L, Amadio M, Venturini L, Buoso E, Magenes G, Govoni S, Ricevuti G, Pascale A
SEARCH RESULTS
330913 RESULTS
PAPER Toyokuni S
Iron as a target of chemoprevention for longevity in humans.
Free Radic Res. 2011 Aug;45(8):906-17. PubMed: 21615276PAPER Rentzos M, Rombos A
The role of IL-15 in central nervous system disorders.
Acta Neurol Scand. 2012 Feb;125(2):77-82. PubMed: 21615353PAPER Yoon JH, Suh MK, Jeong Y, Ahn HJ, Moon SY, Chin J, Seo SW, Na DL
Agraphia in Korean patients with early onset Alzheimer's disease.
Int Psychogeriatr. 2011 Oct;23(8):1317-26. PubMed: 21615977PAPER Mitternacht S, Staneva I, Härd T, Irbäck A
Monte Carlo study of the formation and conformational properties of dimers of Aβ42 variants.
J Mol Biol. 2011 Jul 8;410(2):357-67. PubMed: 21616081PAPER Rytsar R, Fornari E, Frackowiak RS, Ghika JA, Knyazeva MG
Inhibition in early Alzheimer's disease: an fMRI-based study of effective connectivity.
Neuroimage. 2011 Aug 1;57(3):1131-9. PubMed: 21616155PAPER Moghimi SM
Bionanotechnologies for treatment and diagnosis of Alzheimer's disease.
Nanomedicine. 2011 Oct;7(5):515-8. PubMed: 21616169PAPER Engmann O, Hortobágyi T, Thompson AJ, Guadagno J, Troakes C, Soriano S, Al-Sarraj S, Kim Y, Giese KP
Cyclin-dependent kinase 5 activator p25 is generated during memory formation and is reduced at an early stage in Alzheimer's disease.
Biol Psychiatry. 2011 Jul 15;70(2):159-68. PubMed: 21616478PAPER Hudson AE, Hemmings HC
Are anaesthetics toxic to the brain?
Br J Anaesth. 2011 Jul;107(1):30-7. PubMed: 21616941PAPER Carter SF, Caine D, Burns A, Herholz K, Lambon Ralph MA
Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.
Int J Geriatr Psychiatry. 2011 May 25; PubMed: 21618285PAPER Echávarri C, Caballero MC, Aramendía A, García-Bragado F, Tuñón T
Multiprotein deposits in neurodegenerative disorders: our experience in the tissue brain bank of Navarra.
Anat Rec (Hoboken). 2011 Jul;294(7):1191-7. PubMed: 21618706PAPER Rosen BR, Napadow V
Quantitative markers for neuropsychiatric disease: give it a rest.
Radiology. 2011 Apr;259(1):17-9. PubMed: 21436093PAPER Kavanagh S, Gaudig M, Van Baelen B, Adami M, Delgado A, Guzman C, Jedenius E, Schäuble B
Galantamine and behavior in Alzheimer disease: analysis of four trials.
Acta Neurol Scand. 2011 Nov;124(5):302-8. PubMed: 21615354PAPER McGough EL, Kelly VE, Logsdon RG, McCurry SM, Cochrane BB, Engel JM, Teri L
Associations between physical performance and executive function in older adults with mild cognitive impairment: gait speed and the timed "up & go" test.
Phys Ther. 2011 Aug;91(8):1198-207. PubMed: 21616934PAPER Abeti R, Abramov AY, Duchen MR
Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.
Brain. 2011 Jun;134(Pt 6):1658-72. PubMed: 21616968Current Filters
No filters selected